Replimune said on Friday it plans to resubmit the application for its experimental skin cancer drug in the coming days after reaching an agreement with the U.S. FDA, which…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/replimune-gets-third-chance-us-approval-skin-cancer-drug-2026a1000i0b?src=rss
Author :
Publish date : 2026-05-29 12:07:00
Copyright for syndicated content belongs to the linked Source.
